Paper Diagnostics Market Report 2026

Paper Diagnostics Market Overview

• Paper Diagnostics market size has reached to $10.49 billion in 2025 • Expected to grow to $17.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Rising Heart Disease Prevalence Fueling Paper Diagnostics Market Growth • Market Trend: Innovations in Point-of-Care Testing for Enhanced Disease Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Paper Diagnostics Market?

Paper diagnostics are devices that use cellulosic and paper materials to identify and measure chemicals and bio-molecules that have an impact on health. They are utilized in the majority of healthcare settings, including hospitals, doctor's offices, professional sports testing, and maternity clinics. The main types of paper diagnostics are dipsticks, lateral flow assays, and paper-based microfluidics. A urine dipstick test is a urine analysis that involves dipping a particular strip of paper into a urine sample. The various devices include monitoring devices and diagnostic devices. Their various applications include environmental monitoring, clinical diagnostics, and food quality testing, and used by various end-users such as home healthcare, assisted living healthcare facilities, and hospitals and clinics.

What Is The Paper Diagnostics Market Growth Forecast?

The paper diagnostics market size is expected to see rapid growth in the next few years. It will grow to $17.31 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for home-based diagnostics, rising investments in affordable healthcare technologies, expansion of preventive healthcare screening, growing focus on early disease detection, advancements in paper microfluidics technology. Major trends in the forecast period include increasing adoption of rapid point-of-care paper tests, rising demand for low-cost diagnostic solutions, growing use of lateral flow assays, expansion of paper-based microfluidic devices, enhanced focus on disposable and eco-friendly diagnostics.

Global Paper Diagnostics Market Segmentation

1) By Product: Dipsticks, Lateral Flow Assays: Paper-Based Microfluidics 2) By Application: Environmental Monitoring, Clinical Diagnostics, Food Quality Testing 3) By End-User: Home Healthcare, Assisted Living Healthcare Facilities, Hospital And Clinics Subsegments: 1) By Dipsticks: Urinalysis Dipsticks, Blood Glucose Dipsticks, Pregnancy Test Dipsticks, Drug Test Dipsticks 2) By Lateral Flow Assays: Point-Of-Care Testing (POCT) Assays, Rapid Infectious Disease Tests, Cardiovascular Marker Tests, Allergy Tests 3) By Paper-Based Microfluidics: Integrated Microfluidic Devices, Environmental Testing Applications, Food Safety Testing Applications

What Is The Driver Of The Paper Diagnostics Market?

The increasing prevalence of heart diseases is expected to propel the paper diagnostics market going forward. Any condition that has an impact on the cardiovascular system is referred to as heart disease. A sensitive and quick microfluidic paper-based device (PAD) helps in the simultaneous detection of numerous cardiac biomarkers for the early and late diagnosis of acute myocardial infarction, as a result, the increased prevalence of heart diseases increases the demand for paper diagnostics. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of heart diseases is driving the growth of the paper diagnostics industry.

Key Players In The Global Paper Diagnostics Market

Major companies operating in the paper diagnostics market are Abbott Inc, Arkray Inc, Acon Laboratories Inc, Chembio Diagnostic Systems Inc, Abingdon Health, Micro Essential Laboratory Inc, Paperdrop Diagnostics, Diagnostics for All Inc, Mologic Ltd, BioMedomics Inc, EKF Diagnostics Holdings plc, Sysmex Corporation, Siemens Healthineers AG, BioPorto Diagnostics A/S, NanoEnTek Inc, BiognostiX GmbH, BioDot Inc, BioFluidica Inc, Cytodiagnostics Inc, Biopico Systems Inc

Global Paper Diagnostics Market Trends and Insights

Major companies operating in the paper diagnostics market are focusing on developing innovative point-of-care tests to gain a competitive edge in the market. A point-of-care test is a diagnostic test performed at or near the site of patient care, allowing for immediate results and timely clinical decision-making. For instance, in August 2023, Mylab Discovery Solutions, an India-based Mylab Discovery Solutions, launched two rapid point-of-care tests for detecting dengue infections the rapid gold test and the high-accuracy dry luminescence assay test. These tests provide results within 15-20 minutes without the need for a laboratory setup. They can aid in determining the stage and progression of the infection, supporting dengue screening programs in resource-limited regions. The tests differentiate between IgM and IgG antibodies, offering healthcare professionals accurate tools for timely diagnosis and effective disease management.

What Are Latest Mergers And Acquisitions In The Paper Diagnostics Market?

In March 2023, Servier, a France-based pharmaceutical group, partnered with QIAGEN to develop a companion diagnostic test for detecting IDH1 mutations in acute myeloid leukemia (AML) patients. This collaboration is driven by the pivotal clinical phase 3 data from the AGILE study, demonstrating the superior results of ivosidenib in combination with azacitidine for AML patients with IDH1 mutations. QIAGEN, a Germany-based provider of paper diagnostic solutions.

Regional Outlook

North America was the largest region in the paper diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Paper Diagnostics Market?

The paper diagnostics market consists of sales of paper diagnostics for commercial colorimetric tests, and LFA (lateral flow assay) paper-based testing. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.